• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体变体 III 通过刺激粘着斑激酶信号通路使 ERK 磷酸化从而影响神经胶质瘤细胞迁移。

The effect of epidermal growth factor receptor variant III on glioma cell migration by stimulating ERK phosphorylation through the focal adhesion kinase signaling pathway.

机构信息

Department of Biochemistry and Molecular Biology, Fudan University, Shanghai, PR China.

出版信息

Arch Biochem Biophys. 2010 Oct 15;502(2):89-95. doi: 10.1016/j.abb.2010.07.014. Epub 2010 Jul 27.

DOI:10.1016/j.abb.2010.07.014
PMID:20650261
Abstract

Epidermal growth factor receptor variant III (EGFRvIII), the most common EGFR mutation, is associated with cell migration of glioblastoma multiforme (GBM) cases; however, the mechanism has not been elucidated. In this study, we found that the EGFRvIII-promoted glioma cell migration was closely linked to high levels of tyrosine phosphorylation in focal adhesion kinase (FAK) Y397. We also demonstrated that EGFRvIII formed a complex with FAK, resulting in enhanced tyrosine phosphorylation levels of FAK Y397 and EGFR Y1068. After knockdown of FAK expression via anti-FAK shRNA, the U87ΔEGFR cell migration was significantly inhibited, accompanying with the reduced phosphorylation levels of extracellular signal-regulated kinase (ERK1/2). Furthermore, the role of ERK1/2 in FAK-regulated cell migration was confirmed. Taken together, our results suggest that FAK and its downstream molecule ERK were involved in EGFRvIII-promoted glioma cell migration in U87ΔEGFR cells.

摘要

表皮生长因子受体变体 III(EGFRvIII)是最常见的 EGFR 突变,与多形性胶质母细胞瘤(GBM)病例的细胞迁移有关;然而,其机制尚未阐明。在这项研究中,我们发现 EGFRvIII 促进神经胶质瘤细胞迁移与粘着斑激酶(FAK)Y397 处的高酪氨酸磷酸化水平密切相关。我们还证明 EGFRvIII 与 FAK 形成复合物,导致 FAK Y397 和 EGFR Y1068 的酪氨酸磷酸化水平增强。通过抗 FAK shRNA 敲低 FAK 表达后,U87ΔEGFR 细胞迁移显著受到抑制,伴随着细胞外信号调节激酶(ERK1/2)的磷酸化水平降低。此外,还证实了 ERK1/2 在 FAK 调节细胞迁移中的作用。总之,我们的研究结果表明,FAK 及其下游分子 ERK 参与了 U87ΔEGFR 细胞中 EGFRvIII 促进的神经胶质瘤细胞迁移。

相似文献

1
The effect of epidermal growth factor receptor variant III on glioma cell migration by stimulating ERK phosphorylation through the focal adhesion kinase signaling pathway.表皮生长因子受体变体 III 通过刺激粘着斑激酶信号通路使 ERK 磷酸化从而影响神经胶质瘤细胞迁移。
Arch Biochem Biophys. 2010 Oct 15;502(2):89-95. doi: 10.1016/j.abb.2010.07.014. Epub 2010 Jul 27.
2
Loss of focal adhesion kinase (FAK) inhibits epidermal growth factor receptor-dependent migration and induces aggregation of nh(2)-terminal FAK in the nuclei of apoptotic glioblastoma cells.粘着斑激酶(FAK)的缺失会抑制表皮生长因子受体依赖性迁移,并诱导凋亡性胶质母细胞瘤细胞核中FAK氨基末端的聚集。
Cancer Res. 2001 Jul 1;61(13):4978-81.
3
Transinactivation of the epidermal growth factor receptor tyrosine kinase and focal adhesion kinase phosphorylation by dietary flavonoids: effect on invasive potential of human carcinoma cells.膳食类黄酮对表皮生长因子受体酪氨酸激酶的反式失活及粘着斑激酶磷酸化作用:对人癌细胞侵袭潜能的影响
Biochem Pharmacol. 2004 Jun 1;67(11):2103-14. doi: 10.1016/j.bcp.2004.02.023.
4
EGF-induced ERK-activation downstream of FAK requires rac1-NADPH oxidase.表皮生长因子(EGF)诱导的黏着斑激酶(FAK)下游 ERK 的激活需要 rac1-NADPH 氧化酶。
J Cell Physiol. 2011 Sep;226(9):2267-78. doi: 10.1002/jcp.22563.
5
A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.一种新型的粘着斑激酶低分子量抑制剂TAE226可抑制胶质瘤生长。
Mol Carcinog. 2007 Jun;46(6):488-96. doi: 10.1002/mc.20297.
6
Prostaglandin E₂ receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells.前列腺素 E₂ 受体 EP1 介导的粘着斑激酶磷酸化增强肝癌细胞的黏附和迁移。
Int J Oncol. 2013 May;42(5):1833-41. doi: 10.3892/ijo.2013.1859. Epub 2013 Mar 20.
7
Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells.粘着斑激酶:对前列腺素E2介导的肝癌细胞粘附、迁移和侵袭具有重要作用。
Oncol Rep. 2009 Jan;21(1):129-36.
8
Integrin beta1-mediated signaling is involved in transforming growth factor-beta2-promoted migration in human lens epithelial cells.整合素β1介导的信号传导参与转化生长因子-β2促进人晶状体上皮细胞的迁移。
Mol Vis. 2007 Sep 20;13:1769-76.
9
An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK.改变的纤连蛋白基质通过抑制整合素αv水平以及FAK和ERK的磷酸化来诱导人鳞状细胞癌细胞的失巢凋亡。
Apoptosis. 2007 Dec;12(12):2221-31. doi: 10.1007/s10495-007-0138-9.
10
Focal adhesion kinase (FAK) expression and activation during lens development.粘着斑激酶(FAK)在晶状体发育过程中的表达与激活。
Mol Vis. 2007 Mar 26;13:418-30.

引用本文的文献

1
Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment.紫草素抑制肿瘤生长的分子机制及其在癌症治疗中的潜在应用
Toxicol Res (Camb). 2021 Nov 26;10(6):1077-1084. doi: 10.1093/toxres/tfab107. eCollection 2021 Dec.
2
Mutational drivers of cancer cell migration and invasion.癌症细胞迁移和侵袭的突变驱动因素。
Br J Cancer. 2021 Jan;124(1):102-114. doi: 10.1038/s41416-020-01149-0. Epub 2020 Nov 18.
3
MOB2 suppresses GBM cell migration and invasion via regulation of FAK/Akt and cAMP/PKA signaling.
MOB2 通过调节 FAK/Akt 和 cAMP/PKA 信号通路抑制 GBM 细胞迁移和侵袭。
Cell Death Dis. 2020 Apr 14;11(4):230. doi: 10.1038/s41419-020-2381-8.
4
Exploration of Dynamic Elastic Modulus Changes on Glioblastoma Cell Populations with Aberrant EGFR Expression as a Potential Therapeutic Intervention Using a Tunable Hyaluronic Acid Hydrogel Platform.使用可调节透明质酸水凝胶平台探索具有异常表皮生长因子受体(EGFR)表达的胶质母细胞瘤细胞群体的动态弹性模量变化作为一种潜在的治疗干预措施。
Gels. 2017 Jul 13;3(3):28. doi: 10.3390/gels3030028.
5
Oridonin Targets Multiple Drug-Resistant Tumor Cells as Determined by and Analyses.通过[具体方法1]和[具体方法2]分析确定,冬凌草甲素靶向多种耐药肿瘤细胞。
Front Pharmacol. 2018 Apr 16;9:355. doi: 10.3389/fphar.2018.00355. eCollection 2018.
6
Vascular Endothelial Growth Factor, Irradiation, and Axitinib Have Diverse Effects on Motility and Proliferation of Glioblastoma Multiforme Cells.血管内皮生长因子、辐射和阿昔替尼对多形性胶质母细胞瘤细胞的运动性和增殖具有不同影响。
Front Oncol. 2017 Aug 22;7:182. doi: 10.3389/fonc.2017.00182. eCollection 2017.
7
EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment.表皮生长因子受体(EGFR)和截短型表皮生长因子受体变异体III(EGFRvIII)促进胶质母细胞瘤血管生成和细胞侵袭:有效治疗的联合疗法
Int J Mol Sci. 2017 Jun 18;18(6):1295. doi: 10.3390/ijms18061295.
8
Deficiency of SUMO-specific protease 1 induces arsenic trioxide-mediated apoptosis by regulating XBP1 activity in human acute promyelocytic leukemia.SUMO特异性蛋白酶1的缺乏通过调节人急性早幼粒细胞白血病中的XBP1活性诱导三氧化二砷介导的细胞凋亡。
Oncol Lett. 2016 Nov;12(5):3755-3762. doi: 10.3892/ol.2016.5162. Epub 2016 Sep 21.
9
Identification of Glioblastoma Phosphotyrosine-Containing Proteins with Two-Dimensional Western Blotting and Tandem Mass Spectrometry.利用二维蛋白质印迹法和串联质谱法鉴定胶质母细胞瘤中含磷酸酪氨酸的蛋白质
Biomed Res Int. 2015;2015:134050. doi: 10.1155/2015/134050. Epub 2015 May 18.
10
EGFRvIII-mediated transactivation of receptor tyrosine kinases in glioma: mechanism and therapeutic implications.表皮生长因子受体III型变异体(EGFRvIII)介导的胶质瘤中受体酪氨酸激酶的反式激活:机制及治疗意义
Oncogene. 2015 Oct 8;34(41):5277-87. doi: 10.1038/onc.2014.448. Epub 2015 Feb 9.